advertisement
Brubaker JW 21
Showing records 1 to 21 | Display all abstracts from Brubaker JW106098 Effectiveness and Safety of iStent Infinite Trabecular Micro-Bypass for Uncontrolled Glaucoma
Sarkisian SR
Journal of Glaucoma 2023; 32: 9-18
106840 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements
Grippo TM
Clinical Ophthalmology 2023; 17: 71-83
106359 Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies
Weinreb RN
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 55-62
106098 Effectiveness and Safety of iStent Infinite Trabecular Micro-Bypass for Uncontrolled Glaucoma
Grover DS
Journal of Glaucoma 2023; 32: 9-18
106840 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements
Töteberg-Harms M
Clinical Ophthalmology 2023; 17: 71-83
106359 Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies
Bacharach J
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 55-62
106840 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements
Giovingo M
Clinical Ophthalmology 2023; 17: 71-83
106359 Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies
Brubaker JW
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 55-62
106098 Effectiveness and Safety of iStent Infinite Trabecular Micro-Bypass for Uncontrolled Glaucoma
Gallardo MJ
Journal of Glaucoma 2023; 32: 9-18
106359 Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies
Medeiros FA
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 55-62
106098 Effectiveness and Safety of iStent Infinite Trabecular Micro-Bypass for Uncontrolled Glaucoma
Brubaker JW
Journal of Glaucoma 2023; 32: 9-18
106840 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements
Francis BA; de Crom RRMPC
Clinical Ophthalmology 2023; 17: 71-83
106359 Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies
Bejanian M
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 55-62
106098 Effectiveness and Safety of iStent Infinite Trabecular Micro-Bypass for Uncontrolled Glaucoma
Giamporcaro JE; Hornbeak DM
Journal of Glaucoma 2023; 32: 9-18
106840 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements
Jerkins B
Clinical Ophthalmology 2023; 17: 71-83
106359 Bimatoprost Implant Biodegradation in the Phase 3, Randomized, 20-Month ARTEMIS Studies
Bernstein P; Robinson MR
Journal of Ocular Pharmacology and Therapeutics 2023; 39: 55-62
106840 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements
Brubaker JW
Clinical Ophthalmology 2023; 17: 71-83
106098 Effectiveness and Safety of iStent Infinite Trabecular Micro-Bypass for Uncontrolled Glaucoma
Katz LJ; Navratil T
Journal of Glaucoma 2023; 32: 9-18
106840 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements
An J; Radcliffe N
Clinical Ophthalmology 2023; 17: 71-83
106098 Effectiveness and Safety of iStent Infinite Trabecular Micro-Bypass for Uncontrolled Glaucoma
Journal of Glaucoma 2023; 32: 9-18
106840 Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy - Surgical Technique, Post-Operative Care, Expected Outcomes and Retreatment/Enhancements
Noecker R
Clinical Ophthalmology 2023; 17: 71-83
